Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SSS17 in postoperative anemia following hip or knee arthroplasty
NCT07007936Phase 2Not yet recruiting
- Sponsor
- 3SBio
- Start
- Jul 2025
- Primary completion
- Apr 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of SSS-17 in postoperative anemia, sponsored by 3SBio. Planned start Jul 2025; status: not yet recruiting.
02
Drugs
SSS-17
03
Conditions
postoperative anemia
Beyond the preview
Go deeper on NCT07007936.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07007936.